Subsequently, to investigate the role of PRMT2 in RCC metastatic ability in vivo, the same number of ACHN-shCtrl or ACHN-shPRMT2 cells was injected into BALB/c nude mice through the tail vein. Here, PRMT2 is linked to renal cell adenocarcinoma.